电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CD173 抗体 (PE)

This anti- antibody is a 小鼠 单克隆 antibody detecting in FACS. Suitable for 人.
产品编号 ABIN7505873
发货至: 中国

Quick Overview for CD173 抗体 (PE) (ABIN7505873)

抗原

CD173

适用

  • 4
  • 1

宿主

  • 4
小鼠

克隆类型

  • 4
单克隆

标记

  • 4
PE

应用范围

  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

克隆位点

MEM-195
  • 原理

    Anti-Hu CD173 PE

    特异性

    The antibody MEM-195 reacts with CD173 (H2), an extracellular saccharide antigen expressed mainly during early hematopoiesis, it is also expressed on endothelial cells.

    纯化方法

    Purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. Unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.

    免疫原

    Human thrombocytes

    亚型

    IgM
  • 应用备注

    Flow cytometry: The reagent is designed for analysis of human blood cells using 10 μL reagent / 100 μL of whole blood or 106 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.

    限制

    仅限研究用
  • 缓冲液

    Stabilizing Tris buffered saline (TBS), pH 8.0, 15 mM sodium azide

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    4 °C

    储存方法

    Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
  • 抗原

    CD173

    背景

    CD173 (blood group antigen H2) is a fucosylated saccharide (Fuc-alpha-1-2-Gal-beta-1-4-GlcNAc-beta) generated by beta-D-galactoside 2-alpha-L-fucosyltransferase (FUT1). CD173 belongs to markers of early hematopoiesis, it is expressed mainly on CD34-positive hematopoietic progenitor cells. CD173 is a precursor structure of CD174 (Lewis Y) and is also structurally related to CD15 (Lewis X). On endothelial cells CD173 and CD174 are concentrated on pseudopodial extensions responsible for initial contacts between endothelial cells.,Lewis Y, blood group H2 antigen, LeY
You are here:
Chat with us!